{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:07:55Z","timestamp":1747908475815,"version":"3.37.3"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC under IG 2019 - ID. 23118"],"award-info":[{"award-number":["AIRC under IG 2019 - ID. 23118"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-023-01706-6","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T12:02:26Z","timestamp":1693483346000},"page":"1553-1570","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A narrative review for radiation oncologists to implement preoperative partial breast irradiation"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0992-9022","authenticated-orcid":false,"given":"Maria Alessia","family":"Zerella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6795-1181","authenticated-orcid":false,"given":"Giuseppe","family":"Ronci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Dicuonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damaris Patricia","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna Alessandra","family":"Gerardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Rondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Vigorito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Penco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Sargenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Baratella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-6758","authenticated-orcid":false,"given":"Elisa","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-6469","authenticated-orcid":false,"given":"Consuelo","family":"Morigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0943-7471","authenticated-orcid":false,"given":"Sabrina","family":"Kahler-Ribeiro-Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-7439","authenticated-orcid":false,"given":"Viviana Enrica","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-4548","authenticated-orcid":false,"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"De Camilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4484-1832","authenticated-orcid":false,"given":"Giuseppe","family":"Renne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Orecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-3673","authenticated-orcid":false,"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6529-8328","authenticated-orcid":false,"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.critrevonc.2019.06.003","volume":"141","author":"S Corradini","year":"2019","unstructured":"Corradini S et al (2019) Preoperative radiotherapy: a paradigm shift in the treatment of breast cancer? A review of literature. Crit Rev Oncol Hematol 141:102\u2013111","journal-title":"Crit Rev Oncol Hematol"},{"key":"1706_CR2","first-page":"446","volume":"13","author":"C Bourgier","year":"2011","unstructured":"Bourgier C, Calvo FA, Marsiglia H, Mart\u00edn M (2011) Overview of preoperative radiochemotherapy in breast cancer: past or future? Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 13:446\u2013450","journal-title":"Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex"},{"key":"1706_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.779185","volume":"11","author":"Y Deng","year":"2021","unstructured":"Deng Y et al (2021) Impact of preoperative vs postoperative radiotherapy on overall survival of locally advanced breast cancer patients. Front Oncol 11:779185","journal-title":"Front Oncol"},{"key":"1706_CR4","doi-asserted-by":"publisher","first-page":"14288","DOI":"10.1038\/s41598-022-18251-3","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu Z, Chen H, Sun X, Zhang Z (2022) Survival comparison between postoperative and preoperative radiotherapy for stage I\u2013III non-inflammatory breast cancer. Sci Rep 12:14288","journal-title":"Sci Rep"},{"key":"1706_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13058-017-0870-1","volume":"19","author":"J Poleszczuk","year":"2017","unstructured":"Poleszczuk J et al (2017) Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Res BCR 19:75","journal-title":"Breast Cancer Res BCR"},{"issue":"76","key":"1706_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejca.2017.01.022","volume":"1990","author":"FG Riet","year":"2017","unstructured":"Riet FG et al (2017) Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. Eur J Cancer Oxf Engl 1990(76):45\u201351","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"78","key":"1706_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejca.2017.03.027","volume":"1990","author":"CE Coles","year":"2017","unstructured":"Coles CE, Fourquet A, Poortmans P (2017) Preoperative radiation therapy: the \u2018new\u2019 targeted breast cancer treatment? Eur J Cancer Oxf Engl 1990(78):116\u2013117","journal-title":"Eur J Cancer Oxf Engl"},{"key":"1706_CR8","doi-asserted-by":"publisher","first-page":"9767","DOI":"10.3390\/curroncol29120768","volume":"29","author":"A Montero","year":"2022","unstructured":"Montero A, Ci\u00e9rvide R (2022) Preoperative radio(chemo)therapy in breast cancer: time to switch the perspective? Curr Oncol Tor Oncol 29:9767\u20139787","journal-title":"Curr Oncol Tor Oncol"},{"key":"1706_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.radonc.2011.08.017","volume":"102","author":"MA Bollet","year":"2012","unstructured":"Bollet MA et al (2012) Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial. Radiother Oncol J Eur Soc Ther Radiol Oncol 102:82\u201388","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1706_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000507041","volume":"15","author":"C Matuschek","year":"2020","unstructured":"Matuschek C et al (2020) Neoadjuvant Radio(chemo)therapy for breast cancer: an old concept revisited. Breast Care Basel Switz 15:112\u2013117","journal-title":"Breast Care Basel Switz"},{"key":"1706_CR11","unstructured":"Preoperative Breast Irradiation-NCT02941835-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02941835"},{"key":"1706_CR12","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.3390\/cancers14184531","volume":"14","author":"R Ci\u00e9rvide","year":"2022","unstructured":"Ci\u00e9rvide R et al (2022) Primary chemoradiotherapy treatment (PCRT) for HER2+ and triple negative breast cancer patients: a feasible combination. Cancers 14:4531","journal-title":"Cancers"},{"key":"1706_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.radonc.2022.02.033","volume":"170","author":"T Mulliez","year":"2022","unstructured":"Mulliez T et al (2022) Pre-OPerative accelerated radiotherapy for early stage breast cancer patients (POPART): A feasibility study. Radiother Oncol J Eur Soc Ther Radiol Oncol 170:118\u2013121","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1706_CR14","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1120\/jacmp.v16i1.5126","volume":"16","author":"S Yoo","year":"2015","unstructured":"Yoo S, Blitzblau R, Yin F-F, Horton JK (2015) Dosimetric comparison of preoperative single-fraction partial breast radiotherapy techniques: 3D CRT, noncoplanar IMRT, coplanar IMRT, and VMAT. J Appl Clin Med Phys 16:5126","journal-title":"J Appl Clin Med Phys"},{"key":"1706_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.radonc.2013.10.033","volume":"110","author":"F van der Leij","year":"2014","unstructured":"van der Leij F et al (2014) Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation. Radiother Oncol J Eur Soc Ther Radiol Oncol 110:467\u2013470","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1706_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2009.01.041","volume":"76","author":"R Jagsi","year":"2010","unstructured":"Jagsi R et al (2010) Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76:71\u201378","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ijrobp.2009.04.063","volume":"77","author":"EM Nichols","year":"2010","unstructured":"Nichols EM et al (2010) Comparative analysis of the post-lumpectomy target volume versus the use of pre-lumpectomy tumor volume for early-stage breast cancer: implications for the future. Int J Radiat Oncol Biol Phys 77:197\u2013202","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijrobp.2010.09.041","volume":"82","author":"M Palta","year":"2012","unstructured":"Palta M, Yoo S, Adamson JD, Prosnitz LR, Horton JK (2012) Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 82:37\u201342","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/COC.0b013e3182467ffd","volume":"36","author":"EM Nichols","year":"2013","unstructured":"Nichols EM et al (2013) Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy. Am J Clin Oncol 36:232\u2013238","journal-title":"Am J Clin Oncol"},{"key":"1706_CR20","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-15-0822","volume":"21","author":"DA Palma","year":"2015","unstructured":"Palma DA, Louie AV, Rodrigues GB (2015) New strategies in stereotactic radiotherapy for oligometastases. Clin Cancer Res Off J Am Assoc Cancer Res 21:5198\u20135204","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"1706_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.adro.2018.05.002","volume":"3","author":"JW Lischalk","year":"2018","unstructured":"Lischalk JW et al (2018) Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors. Adv Radiat Oncol 3:447\u2013457","journal-title":"Adv Radiat Oncol"},{"key":"1706_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.radonc.2015.09.023","volume":"117","author":"RK Charaghvandi","year":"2015","unstructured":"Charaghvandi RK et al (2015) MRI-guided single fraction ablative radiotherapy for early-stage breast cancer: a brachytherapy versus volumetric modulated arc therapy dosimetry study. Radiother Oncol J Eur Soc Ther Radiol Oncol 117:477\u2013482","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1706_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-018-1191-y","volume":"14","author":"KR Charaghvandi","year":"2019","unstructured":"Charaghvandi KR et al (2019) Single dose partial breast irradiation using an MRI linear accelerator in the supine and prone treatment position. Clin Transl Radiat Oncol 14:1\u20137","journal-title":"Clin Transl Radiat Oncol"},{"key":"1706_CR24","doi-asserted-by":"publisher","first-page":"20170565","DOI":"10.1259\/bjr.20170565","volume":"91","author":"AM Kirby","year":"2018","unstructured":"Kirby AM (2018) Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial? Br J Radiol 91:20170565","journal-title":"Br J Radiol"},{"key":"1706_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.brachy.2020.10.005","volume":"20","author":"LS Campos Magalh\u00e3es Garcia","year":"2021","unstructured":"Campos Magalh\u00e3es Garcia LS, Garcia Trigo ML (2021) Results of accelerated partial breast irradiation in patients not suitable for external beam irradiation stratified by GEC-ESTRO, ASTRO, and ABS guidelines. Brachytherapy 20:315\u2013325","journal-title":"Brachytherapy"},{"key":"1706_CR26","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","volume":"23","author":"I Meattini","year":"2022","unstructured":"Meattini I et al (2022) European Society for radiotherapy and oncology advisory committee in radiation oncology practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol 23:e21\u2013e31","journal-title":"Lancet Oncol"},{"key":"1706_CR27","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1016\/j.prro.2015.02.002","volume":"5","author":"RC Blitzblau","year":"2015","unstructured":"Blitzblau RC et al (2015) A phase 1 trial of preoperative partial breast radiation therapy: Patient selection, target delineation, and dose delivery. Pract Radiat Oncol 5:e513\u2013e520","journal-title":"Pract Radiat Oncol"},{"key":"1706_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0167-8140(89)90037-6","volume":"16","author":"E Van Limbergen","year":"1989","unstructured":"Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R (1989) Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol J Eur Soc Ther Radiol Oncol 16:253\u2013267","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1706_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0167-8140(88)90222-8","volume":"13","author":"F Thomas","year":"1988","unstructured":"Thomas F et al (1988) Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis. Radiother Oncol J Eur Soc Ther Radiol Oncol 13:267\u2013276","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1706_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3747\/co.27.6059","volume":"27","author":"D Tiberi","year":"2020","unstructured":"Tiberi D et al (2020) Tumour response 3 months after neoadjuvant single-fraction radiotherapy for low-risk breast cancer. Curr Oncol Tor Ont 27:155\u2013158","journal-title":"Curr Oncol Tor Ont"},{"key":"1706_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ijrobp.2016.11.030","volume":"97","author":"E Nichols","year":"2017","unstructured":"Nichols E et al (2017) Preoperative accelerated partial breast irradiation for early-stage breast cancer: preliminary results of a prospective, phase 2 trial. Int J Radiat Oncol Biol Phys 97:747\u2013753","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR32","doi-asserted-by":"crossref","unstructured":"Boughey JC et al (2014) Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial. Ann Surg 260:608\u2013614; discussion 614\u2013616","DOI":"10.1097\/SLA.0000000000000924"},{"key":"1706_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000516114","volume":"16","author":"C Thomssen","year":"2021","unstructured":"Thomssen C, Balic M, Harbeck N, Gnant M (2021) St. Gallen\/Vienna 2021: a brief summary of the consensus discussion on customizing therapies for women with early breast cancer. Breast Care 16:135\u2013143","journal-title":"Breast Care"},{"key":"1706_CR34","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.3747\/co.26.4479","volume":"26","author":"K Guidolin","year":"2019","unstructured":"Guidolin K et al (2019) Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy. Curr Oncol Tor Oncol 26:e334\u2013e340","journal-title":"Curr Oncol Tor Oncol"},{"issue":"46","key":"1706_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","volume":"1990","author":"F Sardanelli","year":"2010","unstructured":"Sardanelli F et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer Oxf Engl 1990(46):1296\u20131316","journal-title":"Eur J Cancer Oxf Engl"},{"key":"1706_CR36","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1200\/JCO.2006.06.8080","volume":"24","author":"N Hylton","year":"2006","unstructured":"Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol Off J Am Soc Clin Oncol 24:3293\u20133298","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1706_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1748-717X-9-63","volume":"9","author":"MD den Hartogh","year":"2014","unstructured":"den Hartogh MD et al (2014) MRI and CT imaging for preoperative target volume delineation in breast-conserving therapy. Radiat Oncol Lond Engl 9:63","journal-title":"Radiat Oncol Lond Engl"},{"key":"1706_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12885-017-3144-5","volume":"17","author":"RK Charaghvandi","year":"2017","unstructured":"Charaghvandi RK et al (2017) Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol. BMC Cancer 17:181","journal-title":"BMC Cancer"},{"key":"1706_CR39","first-page":"94","volume":"37","author":"I Meattini","year":"2022","unstructured":"Meattini I et al (2022) Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894). Clin Transl Radiat Oncol 37:94\u2013100","journal-title":"Clin Transl Radiat Oncol"},{"key":"1706_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151601","volume":"48","author":"L Di Pasquale Guadalupe","year":"2020","unstructured":"Di Pasquale Guadalupe L, De Jes\u00fas J, Xiong Y, Rosa M (2020) Tumor size and focality in breast carcinoma: analysis of concordance between radiological imaging modalities and pathological examination at a cancer center. Ann Diagn Pathol 48:151601","journal-title":"Ann Diagn Pathol"},{"key":"1706_CR41","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.ijrobp.2012.10.034","volume":"85","author":"P-Y Bondiau","year":"2013","unstructured":"Bondiau P-Y et al (2013) Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. Int J Radiat Oncol Biol Phys 85:1193\u20131199","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR42","unstructured":"NSABP B-39, RTOG 0413 (2006) A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol HO 4:719\u2013721"},{"key":"1706_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000449388","volume":"92","author":"JW Snider","year":"2017","unstructured":"Snider JW et al (2017) Dosimetric improvements with a novel breast stereotactic radiotherapy device for delivery of preoperative partial-breast irradiation. Oncology 92:21\u201330","journal-title":"Oncology"},{"key":"1706_CR44","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ijrobp.2008.12.037","volume":"75","author":"P-Y Bondiau","year":"2009","unstructured":"Bondiau P-Y et al (2009) Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys 75:1041\u20131047","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0360-3016(98)00507-0","volume":"44","author":"Y Yamada","year":"1999","unstructured":"Yamada Y, Ackerman I, Franssen E, MacKenzie RG, Thomas G (1999) Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys 44:99\u2013104","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR46","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/0360-3016(85)90027-6","volume":"11","author":"R Arriagada","year":"1985","unstructured":"Arriagada R, Mouriesse H, Sarrazin D, Clark RM, Deboer G (1985) Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave\u2013Roussy Institute and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 11:1751\u20131757","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR47","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ijrobp.2015.03.007","volume":"92","author":"JK Horton","year":"2015","unstructured":"Horton JK et al (2015) Preoperative single-fraction partial breast radiation therapy: a novel phase 1, Dose-escalation protocol with radiation response biomarkers. Int J Radiat Oncol Biol Phys 92:846\u2013855","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/1533034615593191","volume":"15","author":"C Wang","year":"2016","unstructured":"Wang C, Horton JK, Yin F-F, Chang Z (2016) Assessment of treatment response with diffusion-weighted MRI and dynamic contrast-enhanced MRI in patients with early-stage breast cancer treated with single-dose preoperative radiotherapy: initial results. Technol Cancer Res Treat 15:651\u2013660","journal-title":"Technol Cancer Res Treat"},{"key":"1706_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.semradonc.2008.04.004","volume":"18","author":"DJ Brenner","year":"2008","unstructured":"Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18:234\u2013239","journal-title":"Semin Radiat Oncol"},{"key":"1706_CR50","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH et al (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37:4078\u20134101","journal-title":"Med Phys"},{"key":"1706_CR51","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB et al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10-19","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijrobp.2017.01.020","volume":"98","author":"A Rahimi","year":"2017","unstructured":"Rahimi A et al (2017) Preliminary results of a phase 1 Dose-escalation trial for early-stage breast cancer using 5-fraction stereotactic body radiation therapy for partial-breast irradiation. Int J Radiat Oncol Biol Phys 98:196-205.e2","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR53","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","volume":"31","author":"IA Olivotto","year":"2013","unstructured":"Olivotto IA et al (2013) Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol Off J Am Soc Clin Oncol 31:4038\u20134045","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1706_CR54","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.ijrobp.2009.01.009","volume":"75","author":"JT Hepel","year":"2009","unstructured":"Hepel JT et al (2009) Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75:1290\u20131296","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1748-717X-6-155","volume":"6","author":"P Pinnar\u00f2","year":"2011","unstructured":"Pinnar\u00f2 P et al (2011) Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol Lond Engl 6:155","journal-title":"Radiat Oncol Lond Engl"},{"key":"1706_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-013-2623-x","volume":"140","author":"RY Lei","year":"2013","unstructured":"Lei RY et al (2013) Four-year clinical update from a prospective trial of accelerated partial breast intensity-modulated radiotherapy (APBIMRT). Breast Cancer Res Treat 140:119\u2013133","journal-title":"Breast Cancer Res Treat"},{"key":"1706_CR57","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijrobp.2020.05.025","volume":"108","author":"A Rahimi","year":"2020","unstructured":"Rahimi A et al (2020) Risk factors for fat necrosis after stereotactic partial breast irradiation for early-stage breast cancer in a phase 1 clinical trial. Int J Radiat Oncol Biol Phys 108:697\u2013706","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR58","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ijrobp.2018.05.059","volume":"102","author":"B Natarajan","year":"2018","unstructured":"Natarajan B et al (2018) Findings on surveillance imaging after preoperative partial breast irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 102:1374\u20131381","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","volume":"18","author":"RD Timmerman","year":"2008","unstructured":"Timmerman RD (2008) An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 18:215\u2013222","journal-title":"Semin Radiat Oncol"},{"key":"1706_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2016.11.005","volume":"109","author":"MR Folkert","year":"2017","unstructured":"Folkert MR, Timmerman RD (2017) Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT). Adv Drug Deliv Rev 109:3\u201314","journal-title":"Adv Drug Deliv Rev"},{"key":"1706_CR61","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0360-3016(02)02785-2","volume":"53","author":"M Deutsch","year":"2002","unstructured":"Deutsch M (2002) Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 53:687\u2013691","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijsu.2018.05.031","volume":"56","author":"H Wu","year":"2018","unstructured":"Wu H et al (2018) Short-course radiotherapy with immediate or delayed surgery in rectal cancer: a meta-analysis. Int J Surg Lond Engl 56:195\u2013202","journal-title":"Int J Surg Lond Engl"},{"key":"1706_CR63","doi-asserted-by":"publisher","first-page":"P4-P4","DOI":"10.1158\/1538-7445.SABCS19-P4-12-07","volume":"80","author":"M-H Ngo","year":"2020","unstructured":"Ngo M-H et al (2020) Abstract P4\u201312-07: single pre-operative radiation therapy (SPORT) trial for low risk breast cancer: a phase 1 study comparing pathological findings in immediate versus delayed surgery. Cancer Res 80:P4-P4-12-07","journal-title":"Cancer Res"},{"key":"1706_CR64","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.ijrobp.2019.11.406","volume":"106","author":"JE Vasmel","year":"2020","unstructured":"Vasmel JE et al (2020) Tumor response after neoadjuvant magnetic resonance guided single ablative dose partial breast irradiation. Int J Radiat Oncol Biol Phys 106:821\u2013829","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR65","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.ijrobp.2019.12.037","volume":"106","author":"SCJ Bosma","year":"2020","unstructured":"Bosma SCJ et al (2020) Five-year results of the preoperative accelerated partial breast irradiation (PAPBI) trial. Int J Radiat Oncol Biol Phys 106:958\u2013967","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR66","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12032-011-9842-y","volume":"29","author":"X-R Li","year":"2012","unstructured":"Li X-R et al (2012) DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol Northwood Lond Engl 29:425\u2013431","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"1706_CR67","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.semradonc.2010.10.004","volume":"21","author":"AR Padhani","year":"2011","unstructured":"Padhani AR (2011) Diffusion magnetic resonance imaging in cancer patient management. Semin Radiat Oncol 21:119\u2013140","journal-title":"Semin Radiat Oncol"},{"key":"1706_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/RCT.0000000000001001","volume":"44","author":"G Lv","year":"2020","unstructured":"Lv G et al (2020) Comparison of model-free and model-based dynamic contrast-enhanced magnetic resonance imaging pharmacokinetic parameters for predicting breast cancers\u2019 response to neoadjuvant chemotherapy. J Comput Assist Tomogr 44:269\u2013274","journal-title":"J Comput Assist Tomogr"},{"key":"1706_CR69","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1016\/j.clbc.2021.06.016","volume":"22","author":"RJ Weinfurtner","year":"2022","unstructured":"Weinfurtner RJ et al (2022) MRI response to pre-operative stereotactic ablative body radiotherapy (SABR) in early stage ER\/PR+ HER2-breast cancer correlates with surgical pathology tumor bed cellularity. Clin Breast Cancer 22:e214\u2013e223","journal-title":"Clin Breast Cancer"},{"key":"1706_CR70","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/cncr.32599","volume":"126","author":"AY Ho","year":"2020","unstructured":"Ho AY et al (2020) A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer. Cancer 126:850\u2013860","journal-title":"Cancer"},{"key":"1706_CR71","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clbc.2020.01.012","volume":"20","author":"R Barroso-Sousa","year":"2020","unstructured":"Barroso-Sousa R et al (2020) A phase II study of pembrolizumab in combination with palliative radiotherapy for hormone receptor-positive metastatic breast cancer. Clin Breast Cancer 20:238\u2013245","journal-title":"Clin Breast Cancer"},{"key":"1706_CR72","first-page":"922","volume":"14","author":"HL McArthur","year":"2016","unstructured":"McArthur HL, Page DB (2016) Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy. Clin Adv Hematol Oncol HO 14:922\u2013933","journal-title":"Clin Adv Hematol Oncol HO"},{"key":"1706_CR73","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.breast.2017.01.013","volume":"37","author":"ML Disis","year":"2018","unstructured":"Disis ML, Stanton SE (2018) Immunotherapy in breast cancer: an introduction. Breast Edinb Scotl 37:196\u2013199","journal-title":"Breast Edinb Scotl"},{"key":"1706_CR74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11912-017-0627-0","volume":"19","author":"F Bertucci","year":"2017","unstructured":"Bertucci F, Gon\u00e7alves A (2017) Immunotherapy in breast cancer: the emerging role of PD-1 and PD-L1. Curr Oncol Rep 19:64","journal-title":"Curr Oncol Rep"},{"key":"1706_CR75","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.breast.2017.05.013","volume":"37","author":"MR Nathan","year":"2018","unstructured":"Nathan MR, Schmid P (2018) The emerging world of breast cancer immunotherapy. Breast Edinb Scotl 37:200\u2013206","journal-title":"Breast Edinb Scotl"},{"key":"1706_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijrobp.2020.05.011","volume":"108","author":"AY Ho","year":"2020","unstructured":"Ho AY et al (2020) Optimizing radiation therapy to boost systemic immune responses in breast cancer: a critical review for breast radiation oncologists. Int J Radiat Oncol Biol Phys 108:227\u2013241","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1706_CR77","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000355196","volume":"85","author":"H Mukai","year":"2013","unstructured":"Mukai H et al (2013) Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306. Oncology 85:336\u2013341","journal-title":"Oncology"},{"key":"1706_CR78","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S1470-2045(22)00613-1","volume":"23","author":"HM Kuerer","year":"2022","unstructured":"Kuerer HM et al (2022) Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol 23:1517\u20131524","journal-title":"Lancet Oncol"},{"key":"1706_CR79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijrobp.2019.09.002","volume":"106","author":"SCJ Bosma","year":"2020","unstructured":"Bosma SCJ et al (2020) Response to preoperative radiation therapy in relation to gene expression patterns in breast cancer patients. Int J Radiat Oncol Biol Phys 106:174\u2013181","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"82","key":"1706_CR80","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejca.2017.06.014","volume":"1990","author":"SV Lightowlers","year":"2017","unstructured":"Lightowlers SV et al (2017) Preoperative breast radiation therapy: indications and perspectives. Eur J Cancer Oxf Engl 1990(82):184\u2013192","journal-title":"Eur J Cancer Oxf Engl"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-023-01706-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01706-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T14:06:45Z","timestamp":1701871605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-023-01706-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":80,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s11547-023-01706-6","relation":{},"ISSN":["1826-6983"],"issn-type":[{"type":"electronic","value":"1826-6983"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IEO, the European Institute of Oncology, is partially supported by Institutional grants from Accuray Inc. and Ion Beam Applications (IBA). Prof. Jereczek-Fossa reports personal fees for lecturers, presentations or participation on data safety monitoring or advisory boards from ESTRO, ESO, ASCO, ROCHE, BAYER, JANSSEN, CARL ZEISS, ACCURAY, ASTELLAS, ELEKTA, IBA and ACCMED outside the submitted work. MCL received speakers fee from Accuray and SD received speakers fee from Accuray Asia (all outside the current project). All the other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}